Silo Pharma

Silo Pharma is a for-profit, listed, bio-pharma company aiming to commercialize psychedelics.

Silo Pharma

The company is listed on the OTCQB Venture Market. It is working together with Maastricht University on a study with psilocybin and LSD for Parkinson’s.

The company was previously called ‘Uppercut Brands’ and sold ‘urban fashion’ online.

In December 2021, Silo announced it has entered into Securities Purchase Agreements with certain existing institutional and accredited investors for a $4.275 million fixed-price convertible preferred equity financing.

Key Staff


Company Information

Silo Pharma Website

September, 2020


B2B B2C Pharmaceutical

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships